Literature DB >> 6449005

Switching on the macrophage-mediated suppressor mechanism by tumor cells to evade host immune surveillance.

C C Ting, D Rodrigues.   

Abstract

The present study demonstrates a unique mechanism for tumor cell-induced immunosuppression. In the presence of a nonsuppressive dose of tumor cells, generation of cytotoxic T cells in the mixed lymphocyte culture (MLC) is completely suppressed by adding exogenous (peritoneal) macrophages (PM phi) after the initiation of the MLC. This indicates that tumor cells can switch on a suppressor mechanism through host macrophages. It has further been determined that suppression can be induced only if resident (splenic) macrophages (SM phi) are exposed to tumor cells prior to addition of PM phi. If SM phi and PM phi are simultaneously present with the tumor cells, induction of suppression is completely precluded. These findings indicate that switching on of the suppressor mechanism by tumor cells has a critical requirement for the collaboration of two populations of macrophages, SM phi and PM phi, and their presence in a specific sequence (SM phi preceding PM phi). This may represent one of the mechanisms by which tumor cells evade host immune surveillance.

Entities:  

Mesh:

Year:  1980        PMID: 6449005      PMCID: PMC349813          DOI: 10.1073/pnas.77.7.4265

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Inhibition of rat mixed lymphocyte cultures by suppressor macrophages.

Authors:  J R Oehler; R B Herberman; D A Campbell; J Y Djeu
Journal:  Cell Immunol       Date:  1977-03-15       Impact factor: 4.868

2.  Control of the immune response: role of macrophages in regulation of antibody-and cell-mediated immune responses.

Authors:  R M Gorczynski
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

3.  Cell-mediated immunity to Friend virus-induced leukemia. I. Modification of 125IUdR release cytotoxicity assay for use with suspension target cells.

Authors:  G S Bushar; D Rodrigues; R B Herberman
Journal:  J Immunol       Date:  1975-11       Impact factor: 5.422

4.  Inhibition of the mixed lymphocyte culture by peritoneal exudate cells.

Authors:  B R Fernbach; H Kirchner; R B Herberman
Journal:  Cell Immunol       Date:  1976-03-15       Impact factor: 4.868

5.  Separation of mouse spleen cells by passage through columns of sephadex G-10.

Authors:  I A Ly; R I Mishell
Journal:  J Immunol Methods       Date:  1974-08       Impact factor: 2.303

6.  Cell-mediated cell lysis in vitro: genetic control of killer cell production and target specificities in the mouse.

Authors:  M Nabholz; J Vives; H M Young; T Meo; V Miggiano; A Rijnbeek; D C Shreffler
Journal:  Eur J Immunol       Date:  1974-05       Impact factor: 5.532

7.  Cross-resistance to the transplantation of syngeneic Friend, Moloney, and Rauscher virus-induced tumors.

Authors:  J P Glynn; J L McCoy; A Fefer
Journal:  Cancer Res       Date:  1968-03       Impact factor: 12.701

8.  Immunodepression and malignancy.

Authors:  O Stutman
Journal:  Adv Cancer Res       Date:  1975       Impact factor: 6.242

9.  Two antigenically different types of macrophages.

Authors:  I Montfort; R Pérez Tamayo
Journal:  Proc Soc Exp Biol Med       Date:  1971-10

10.  Properties of cell lines derived from tumors induced by Friend virus in BALB/c and BALB/c-H-2b mice.

Authors:  H A Freedman; F Lilly
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

View more
  6 in total

1.  Changes in immune reactivity during growth of an adenovirus 12-induced transplantable tumour in CBA mice.

Authors:  V Britten; J C Underwood
Journal:  Experientia       Date:  1981-05-15

2.  Association of macrophages detected with monoclonal antibody 25 F 9 with progression and pathobiological classification of gastric carcinoma.

Authors:  G Heidl; P Davaris; G Zwadlo; M S Jagoda; S Düchting; E Bierhoff; T Grüter; V Krieg; C Sorg
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

3.  Immunosuppression in murine renal cell carcinoma. I. Characterization of extent, severity and sources.

Authors:  S K Gregorian; J R Battisto
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

4.  Autologous anticancer antigen preparation for specific immunotherapy in advanced cancer patients. A phase I clinical trial.

Authors:  C A Slanetz; D L McCollester; S Kanor
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

5.  Immunosuppression in murine renal cell carcinoma. II. Identification of responsible lymphoid cell phenotypes and examination of elimination of suppression.

Authors:  S K Gregorian; J R Battisto
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

6.  Temporal transcriptome changes induced by MDV in Marek's disease-resistant and -susceptible inbred chickens.

Authors:  Ying Yu; Juan Luo; Apratim Mitra; Shuang Chang; Fei Tian; Huanmin Zhang; Ping Yuan; Huaijun Zhou; Jiuzhou Song
Journal:  BMC Genomics       Date:  2011-10-12       Impact factor: 3.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.